Used in research as a selective agonist for group II metabotropic glutamate receptors (mGluR2 and mGluR3), this compound helps study neurological pathways involved in anxiety, schizophrenia, and neurodegenerative diseases. It is valued for its ability to modulate synaptic transmission without over-activating ionotropic glutamate receptors, reducing the risk of excitotoxicity. Its stereospecific configuration enhances receptor selectivity, making it a useful tool in neuropharmacology and drug development.